linked in pixel

RELEASE DATE: April 14, 2022

Researchers at Ochsner Health have earned the honor of being labeled in the top 2% of their fields worldwide, according to a 2021 Stanford University study that ranks researchers based on the impact of their publications. The distinction reinforces Ochsner’s commitment to excellence and innovation in healthcare, education, and research, with a mission to lead and to serve.

The ranking, considered the most prestigious worldwide, measures academic achievement based on bibliometric information and includes more than 160,000 researchers from the more than 8 million scientists considered to be active around the globe. Altogether, 22 scientific fields and 176 subfields are considered in the list.

The Stanford database is divided into two categories: career-long citation impact and single-year impact. Based on 2020 results, these 12 Ochsner researchers were recognized in 2021 as among the world’s top 2% of scientists ranked in the world:

  • J.R. Biggio, MD, System Chair, Women’s Services and System Chair, Maternal-Fetal Medicine at Ochsner Baptist
  • Lawrence Blonde, MD, Director, Ochsner Diabetes Clinical Research Unit
  • S.B. Deitelzweig, MD, System Department Chair of Hospital Medicine and Vice President of Medical Affairs for Ochsner Health
  • Edward Frohlich, MD, Alton Ochsner Distinguished Scientist at Ochsner Clinic Foundation (deceased)
  • Carl “Chip” Lavie, MD, Ochsner’s Medical Director of Cardiac Rehabilitation and Prevention
  • Edward McCoul, MD, Rhinology Specialist at Ochsner Health
  • Richard Milani, MD, Chief Clinical Transformation Officer at Ochsner Health
  • George Pankey, MD, Ochsner’s Director of Infectious Diseases Research
  • Eboni Price-Haywood, MD, MPH, FACP, Medical Director at Ochsner Xavier Institute for Health Equity and Research
  • Gabriel Uwaifo, MD, Endocrinology, Diabetes & Metabolism Specialist
  • Hector Ventura, MD, Section Head Heart Failure and Heart Transplant at Ochsner Clinic Foundation
  • Christopher White, System Chairman for Cardiovascular Disease and Director, John Ochsner Heart & Vascular Institute

Full details with data sets are available here.